These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11562928)

  • 1. Motivations and psychosocial impact of genetic testing for HNPCC.
    Esplen MJ; Madlensky L; Butler K; McKinnon W; Bapat B; Wong J; Aronson M; Gallinger S
    Am J Med Genet; 2001 Sep; 103(1):9-15. PubMed ID: 11562928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
    Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.
    Keller M; Jost R; Haunstetter CM; Sattel H; Schroeter C; Bertsch U; Cremer F; Kienle P; Tariverdian M; Kloor M; Gebert J; Brechtel A
    Clin Genet; 2008 Nov; 74(5):414-24. PubMed ID: 18954412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
    Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
    J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):71-7. PubMed ID: 17045473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V; Meiser B; Gaff C; St John DJ; Halliday J
    Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
    Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
    Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
    Claes E; Denayer L; Evers-Kiebooms G; Boogaerts A; Legius E
    Patient Educ Couns; 2004 Nov; 55(2):265-74. PubMed ID: 15530764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.